AQUASOL A Drug Patent Profile
✉ Email this page to a colleague
When do Aquasol A patents expire, and when can generic versions of Aquasol A launch?
Aquasol A is a drug marketed by Astrazeneca and Casper Pharma Llc and is included in two NDAs.
The generic ingredient in AQUASOL A is vitamin a palmitate. There are fifty drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the vitamin a palmitate profile page.
US Patents and Regulatory Information for AQUASOL A
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca | AQUASOL A | vitamin a | CAPSULE;ORAL | 083080-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Astrazeneca | AQUASOL A | vitamin a | CAPSULE;ORAL | 083080-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Casper Pharma Llc | AQUASOL A | vitamin a palmitate | INJECTABLE;INJECTION | 006823-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
